National Research Corp Aktie
?
Deine Einschätzung
National Research Corp Aktie
Was spricht für und gegen National Research Corp in den nächsten Jahren?
Pro
Kontra
Rendite von National Research Corp im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| National Research Corp | -1,73 % | - | - | - | - | - | - |
| Newtek Business Services Inc. | 2,98 % | 17,65 % | 17,42 % | -3,40 % | 22,61 % | -25,88 % | - |
| Mistras Group Inc. | 2,68 % | 4,67 % | 9,80 % | 31,76 % | 4,67 % | 38,27 % | 52,38 % |
| ICF International Inc. | -2,48 % | 11,03 % | 7,33 % | -30,00 % | 8,78 % | -14,36 % | 25,78 % |
Kommentare
News
NRC Health Announces Third Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2025.
“We delivered our
NRC Health Announces Shane Harrison as Chief Financial Officer
National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare experience, is pleased to announce the appointment of Shane Harrison as its
NRC Health Announces Second Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2025.
CEO Statement
Trent S. Green, Chief Executive Officer of NRC Health



